Liver Cancer Registry Platform

Recruiting now

Conditions studied: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma

In brief

The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma (CCC) in Germany.

Key facts

Study ID

NCT04510740

Run by

iOMEDICO AG

People needed

1000

Starts

2020-08-09

Expected to finish

2027-12-01

Last updated by the study team

2026-06-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCC) als early, intermediate or advanced/metastatic stage
• Age ≥ 18 years
• Signed and dated informed consent (IC):
• For participation in the PRO module: Before primary locoregional therapy or start of first systemic treatment
• For no participation in the PRO module: No later than 8 weeks after primary locoregional therapy or start of first systemic treatment

You may not qualify if…

• Patients treated with best supportive care (BSC) only (i.e. no surgery, no radiotherapy, no ablative procedures, no systemic anti-tumoral therapies)

Where it is running

• Multiple sites all over germany — Multiple Sites, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.